We explored an association between inflammatory response-associated signature and immune infiltration in IDD and validated that IL-1β, LYN, and NAMPT might serve as biomarkers and therapeutic targets for IDD in the future. This evidence concerns the gene IL1B and intervertebral disk degenerative disorder.